* FTSE 100 index sheds 0.3 percent
* Worries build ahead of UK Q3 earnings season
* Shire heads weak drugmakers
* Broker comment positive for mining stocks
By Jon Hopkins
LONDON, Oct 22 (Reuters) - Britain's top share index lost
ground on Monday, extending declines on concerns about upcoming
third quarter earnings.
Drugmakers dipped, with Shire down 1.8 percent and
AstraZeneca off 0.5 percent. The firms kick off the
heavyweight sector's results season on Thursday.
According to Thomson Reuters Starmine data, of the 8 percent
of European companies that have reported results so far, nearly
half have missed forecasts.
TR Starmine analysts have estimated year-on-year
third-quarter earnings growth at 7.6 percent in Europe, while
the average for companies that have already reported is a 4.2
percent drop.
At the close, the FTSE 100 was down 17.82 points, or
0.3 percent, at 5,882.91 points, having shed 0.4 percent on
Friday to snap a four-session winning streak.
UK blue chips tracked weakness in their U.S. peers, with the
Dow Jones off 0.3 percent by London's close, having
dropped sharply on Friday, also pressured by earnings concerns.
Among the U.S. fallers, mining company Freeport-McMoRan
lost 0.9 percent after its third-quarter profit fell
sharply, missing Wall Street estimates.
UK-listed miners, however, featured on the FTSE
leaderboard, steadying after falls on Friday, with traders
citing support from positive European strategy comments from
Morgan Stanley.
The bank's strategists switched their preference to miners
from chemicals within European materials, which is their
preferred cyclical sector, citing relative valuations and signs
of an improving economic outlook in China.
"I think the mining sector is not that widely owned,
particularly amongst the UK long-only community. Miners have
been consensus underweight for some time, and therefore people
at a minimum will start closing their underweight positions,
which will put upward pressure on share prices", said Graham
Secker, equity strategist at Morgan Stanley.
Gold miner Randgold Resources gainer, up 2.7 percent on a firmer gold price following a hike in target price by Societe Generale to 9,000 pence from 7,600. Precious metals firm Johnson Matthey missed out on the sector gains, falling 2.1 percent having spiked by a similar amount in the previous session on speculative interest. Andrew Gibson, Head of Research at Galvan said the share represented a buying opportunity, citing technical factors. (Reporting By Francesco Canepa; Editing by John Stonestreet)
Source: http://news.yahoo.com/earnings-concerns-weigh-uk-shares-155601039--business.html
tri international criminal court ios 5.1 apple tv update new ipad release pregnant jessica simpson international womens day
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.